pharmaceutical investing Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
pharmaceutical investing EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
Revolve Receives Approval from the Alberta Utilities Commission for the 15.7 MW Bright Meadows Solar Project
